<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459161</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Nucleocapsid Protein Antagonizes GADD34-Mediated Innate Immune Pathway through Atypical Foci.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4792</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules29204792</ELocationID><Abstract><AbstractText>The integrated stress response, especially stress granules (SGs), contributes to host immunity. Typical G3BP1<sup>+</sup> stress granules (tSGs) are usually formed after virus infection to restrain viral replication and stimulate innate immunity. Recently, several SG-like foci or atypical SGs (aSGs) with proviral function have been found during viral infection. We have shown that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein induces atypical N<sup>+</sup>/G3BP1<sup>+</sup> foci (N<sup>+</sup>foci), leading to the inhibition of host immunity and facilitation of viral infection. However, the precise mechanism has not been well clarified yet. In this study, we showed that the SARS-CoV-2 N (SARS2-N) protein inhibits dsRNA-induced growth arrest and DNA damage-inducible 34 (GADD34) expression. Mechanistically, the SARS2-N protein promotes the interaction between <i>GADD34</i> mRNA and G3BP1, sequestering <i>GADD34</i> mRNA into the N<sup>+</sup>foci. Importantly, we found that GADD34 participates in IRF3 nuclear translocation through its KVRF motif and promotes the transcription of downstream interferon genes. The suppression of GADD34 expression by the SARS2-N protein impairs the nuclear localization of IRF3 and compromises the host's innate immune response, which facilitates viral replication. Taking these findings together, our study revealed a novel mechanism by which the SARS2-N protein antagonized the GADD34-mediated innate immune pathway via induction of N<sup>+</sup>foci. We think this is a critical strategy for viral pathogenesis and has potential therapeutic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Guanwen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chunxiu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bingbing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Kaifei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Su</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Naru</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Geng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7557-2968</Identifier><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Tiejun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32370147; 31970755</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2023R5242</GrantID><Agency>the Special Support Program for High-level Talents in Zhejiang Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086462">Coronavirus Nucleocapsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067776">RNA Recognition Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D054645">Protein Phosphatase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="C087519">PPP1R15A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C116070">G3BP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494232">IRF3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086462" MajorTopicYN="Y">Coronavirus Nucleocapsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="Y">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067776" MajorTopicYN="Y">RNA Recognition Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054645" MajorTopicYN="Y">Protein Phosphatase 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000088162" MajorTopicYN="N">Stress Granules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GADD34</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">nucleocapsid protein</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459161</ArticleId><ArticleId IdType="pmc">PMC11510332</ArticleId><ArticleId IdType="doi">10.3390/molecules29204792</ArticleId><ArticleId IdType="pii">molecules29204792</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006;7:131–137. doi: 10.1038/ni1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1303</ArticleId><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A., Reis e Sousa C. Innate Recognition of Viruses. Immunity. 2007;27:370–383. doi: 10.1016/j.immuni.2007.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.08.012</ArticleId><ArticleId IdType="pubmed">17892846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 2010;11:373–384. doi: 10.1038/ni.1863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1863</ArticleId><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005;6:981–988. doi: 10.1038/ni1243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.-M., Maniatis T. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003;4:491–496. doi: 10.1038/ni921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan N., Chen Z.J. Intrinsic antiviral immunity. Nat. Immunol. 2012;13:214–222. doi: 10.1038/ni.2229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2229</ArticleId><ArticleId IdType="pmc">PMC3549670</ArticleId><ArticleId IdType="pubmed">22344284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Sui L., Wu P., Wang W., Wang Z., Yu Y., Hou Z., Tan G., Liu Q., Wang G. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct. Target. Ther. 2021;6:331. doi: 10.1038/s41392-021-00742-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00742-w</ArticleId><ArticleId IdType="pmc">PMC8409078</ArticleId><ArticleId IdType="pubmed">34471099</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas R.S., Crum T.F., Parvatiyar K. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3. Front. Cell. Infect. Microbiol. 2022;11:789462. doi: 10.3389/fcimb.2021.789462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.789462</ArticleId><ArticleId IdType="pmc">PMC8785962</ArticleId><ArticleId IdType="pubmed">35083167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui L., Zhao Y., Wang W., Wu P., Wang Z., Yu Y., Hou Z., Tan G., Liu Q. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production through Ubiquitin-Mediated Degradation of TBK1. Front. Immunol. 2021;12:662989. doi: 10.3389/fimmu.2021.662989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.662989</ArticleId><ArticleId IdType="pmc">PMC8168463</ArticleId><ArticleId IdType="pubmed">34084167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Ishida R., Strilets T., Cole J., Lopez-Orozco J., Fayad N., Felix-Lopez A., Elaish M., Evseev D., Magor K.E., et al. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors. J. Virol. 2021;95:e0026621. doi: 10.1128/JVI.00266-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00266-21</ArticleId><ArticleId IdType="pmc">PMC8316110</ArticleId><ArticleId IdType="pubmed">34110264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L., Ren L., et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 2020;11:3810. doi: 10.1038/s41467-020-17665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S.-Y., Siu K.-L., Lin H., Yeung M.L., Jin D.-Y. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. Int. J. Biol. Sci. 2021;17:1547–1554. doi: 10.7150/ijbs.59943.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59943</ArticleId><ArticleId IdType="pmc">PMC8071772</ArticleId><ArticleId IdType="pubmed">33907518</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y.-C., Wang H., Menachery V.D., Rajsbaum R., Shi P.-Y. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin D.-Y., Vazquez C., Swanson S.E., Negatu S.G., Dittmar M., Miller J., Ramage H.R., Cherry S., Jurado K.A. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS ONE. 2021;16:e0253089. doi: 10.1371/journal.pone.0253089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253089</ArticleId><ArticleId IdType="pmc">PMC8224853</ArticleId><ArticleId IdType="pubmed">34166398</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zhuang M.W., Deng J., Zheng Y., Zhang J., Nan M.L., Zhang X.J., Gao C., Wang P.H. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways. J. Med. Virol. 2021;93:5376–5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Sharma N.R., Zheng Z.-M., Chen M. Viral Regulation of RNA Granules in Infected Cells. Virol. Sin. 2019;34:175–191. doi: 10.1007/s12250-019-00122-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00122-3</ArticleId><ArticleId IdType="pmc">PMC6513825</ArticleId><ArticleId IdType="pubmed">31037644</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M.G., Loschi M., Desbats M.A., Boccaccio G.L. RNA granules: The good, the bad and the ugly. Cell. Signal. 2011;23:324–334. doi: 10.1016/j.cellsig.2010.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2010.08.011</ArticleId><ArticleId IdType="pmc">PMC3001194</ArticleId><ArticleId IdType="pubmed">20813183</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick C., Khaperskyy D.A. Translation inhibition and stress granules in the antiviral immune response. Nat. Rev. Immunol. 2017;17:647–660. doi: 10.1038/nri.2017.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.63</ArticleId><ArticleId IdType="pubmed">28669985</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson R.J., Hellen C.U.T., Pestova T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 2010;11:113–127. doi: 10.1038/nrm2838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2838</ArticleId><ArticleId IdType="pmc">PMC4461372</ArticleId><ArticleId IdType="pubmed">20094052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Li J., Fan S., Jin Z., Huang C. Targeting stress granules: A novel therapeutic strategy for human diseases. Pharmacol. Res. 2020;161:105143. doi: 10.1016/j.phrs.2020.105143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105143</ArticleId><ArticleId IdType="pmc">PMC7428673</ArticleId><ArticleId IdType="pubmed">32814168</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownsword M.J., Locker N. A little less aggregation a little more replication: Viral manipulation of stress granules. WIREs RNA. 2022;14:e1821. doi: 10.1002/wrna.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1741</ArticleId><ArticleId IdType="pmc">PMC10078398</ArticleId><ArticleId IdType="pubmed">35709333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa K., Narayanan K., Wada M., Makino S., Gallagher T. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication. J. Virol. 2018;92:e00902-18. doi: 10.1128/JVI.00902-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-18</ArticleId><ArticleId IdType="pmc">PMC6158436</ArticleId><ArticleId IdType="pubmed">30068649</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J.W. Interferon-stimulated genes: Roles in viral pathogenesis. Curr. Opin. Virol. 2014;6:40–46. doi: 10.1016/j.coviro.2014.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.006</ArticleId><ArticleId IdType="pmc">PMC4077717</ArticleId><ArticleId IdType="pubmed">24713352</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello V., Lloyd R.E. How Do Viruses Interact with Stress-Associated RNA Granules? PLoS Pathog. 2012;8:e1002741. doi: 10.1371/journal.ppat.1002741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002741</ArticleId><ArticleId IdType="pmc">PMC3386173</ArticleId><ArticleId IdType="pubmed">22761570</ArticleId></ArticleIdList></Reference><Reference><Citation>White J.P., Lloyd R.E. Regulation of stress granules in virus systems. Trends Microbiol. 2012;20:175–183. doi: 10.1016/j.tim.2012.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2012.02.001</ArticleId><ArticleId IdType="pmc">PMC3322245</ArticleId><ArticleId IdType="pubmed">22405519</ArticleId></ArticleIdList></Reference><Reference><Citation>Poblete-Durán N., Prades-Pérez Y., Vera-Otarola J., Soto-Rifo R., Valiente-Echeverría F. Who Regulates Whom? An Overview of RNA Granules and Viral Infections. Viruses. 2016;8:180. doi: 10.3390/v8070180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8070180</ArticleId><ArticleId IdType="pmc">PMC4974515</ArticleId><ArticleId IdType="pubmed">27367717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnow P., Yang X., Hu Z., Fan S., Zhang Q., Zhong Y., Guo D., Qin Y., Chen M. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation. PLoS Pathog. 2018;14:e1006901. doi: 10.1371/journal.ppat.1006901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006901</ArticleId><ArticleId IdType="pmc">PMC5819834</ArticleId><ArticleId IdType="pubmed">29415027</ArticleId></ArticleIdList></Reference><Reference><Citation>Heise M.T., Götte B., Panas M.D., Hellström K., Liu L., Samreen B., Larsson O., Ahola T., McInerney G.M. Separate domains of G3BP promote efficient clustering of alphavirus replication complexes and recruitment of the translation initiation machinery. PLoS Pathog. 2019;15:e1007842. doi: 10.1371/journal.ppat.1007842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007842</ArticleId><ArticleId IdType="pmc">PMC6594655</ArticleId><ArticleId IdType="pubmed">31199850</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholte F.E.M., Tas A., Albulescu I.C., Žusinaite E., Merits A., Snijder E.J., van Hemert M.J., Diamond M.S. Stress Granule Components G3BP1 and G3BP2 Play a Proviral Role Early in Chikungunya Virus Replication. J. Virol. 2015;89:4457–4469. doi: 10.1128/JVI.03612-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03612-14</ArticleId><ArticleId IdType="pmc">PMC4442398</ArticleId><ArticleId IdType="pubmed">25653451</ArticleId></ArticleIdList></Reference><Reference><Citation>Heise M.T., Kim D.Y., Reynaud J.M., Rasalouskaya A., Akhrymuk I., Mobley J.A., Frolov I., Frolova E.I. New World and Old World Alphaviruses Have Evolved to Exploit Different Components of Stress Granules, FXR and G3BP Proteins, for Assembly of Viral Replication Complexes. PLoS Pathog. 2016;12:e1005810. doi: 10.1371/journal.ppat.1005810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005810</ArticleId><ArticleId IdType="pmc">PMC4980055</ArticleId><ArticleId IdType="pubmed">27509095</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillon P., Rao C.D., Dermody T.S. Rotavirus Induces Formation of Remodeled Stress Granules and P Bodies and Their Sequestration in Viroplasms to Promote Progeny Virus Production. J. Virol. 2018;92:e01363-18. doi: 10.1128/JVI.01363-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01363-18</ArticleId><ArticleId IdType="pmc">PMC6258942</ArticleId><ArticleId IdType="pubmed">30258011</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Li Z., Zhao T., Ju X., Ma P., Jin B., Zhou Y., He S., Huang J., Xu X., et al. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production. Sci. Bull. 2021;66:1194–1204. doi: 10.1016/j.scib.2021.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2021.01.013</ArticleId><ArticleId IdType="pmc">PMC7816596</ArticleId><ArticleId IdType="pubmed">33495715</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Gou H., Zhou Y., Wu C., Ren X., Wu X., Guan G., Jin B., Huang J., Jin Z., et al. The SARS-CoV-2 nucleocapsid protein suppresses innate immunity by remodeling stress granules to atypical foci. FASEB J. 2023;37:e23269. doi: 10.1096/fj.202201973RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202201973RR</ArticleId><ArticleId IdType="pubmed">37889852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T., Jiang X., Xin H., Zheng X., Xue X., Chen J.-L., Qi B. GADD34-mediated dephosphorylation of eIF2α facilitates pseudorabies virus replication by maintaining de novo protein synthesis. Vet. Res. 2021;52:148. doi: 10.1186/s13567-021-01018-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-021-01018-5</ArticleId><ArticleId IdType="pmc">PMC8686791</ArticleId><ArticleId IdType="pubmed">34930429</ArticleId></ArticleIdList></Reference><Reference><Citation>Magg V., Manetto A., Kopp K., Wu C.C., Naghizadeh M., Lindner D., Eke L., Welsch J., Kallenberger S.M., Schott J., et al. Turnover of PPP1R15A mRNA encoding GADD34 controls responsiveness and adaptation to cellular stress. Cell Rep. 2024;43:114069. doi: 10.1016/j.celrep.2024.114069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2024.114069</ArticleId><ArticleId IdType="pubmed">38602876</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy M.S., Yusoff P., Lee I.C., Newton J.C., Goh C.W., Page R., Shenolikar S., Peti W. Structural and Functional Analysis of the GADD34:PP1 eIF2α Phosphatase. Cell Rep. 2015;11:1885–1891. doi: 10.1016/j.celrep.2015.05.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.05.043</ArticleId><ArticleId IdType="pmc">PMC4489983</ArticleId><ArticleId IdType="pubmed">26095357</ArticleId></ArticleIdList></Reference><Reference><Citation>Heise M.T., Clavarino G., Cláudio N., Couderc T., Dalet A., Judith D., Camosseto V., Schmidt E.K., Wenger T., Lecuit M., et al. Induction of GADD34 Is Necessary for dsRNA-Dependent Interferon-β Production and Participates in the Control of Chikungunya Virus Infection. PLoS Pathog. 2012;8:e1002708. doi: 10.1371/journal.ppat.1002708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002708</ArticleId><ArticleId IdType="pmc">PMC3355096</ArticleId><ArticleId IdType="pubmed">22615568</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalet A., Argüello R.J., Combes A., Spinelli L., Jaeger S., Fallet M., Vu Manh T.P., Mendes A., Perego J., Reverendo M., et al. Protein synthesis inhibition and GADD34 control IFN-β heterogeneous expression in response to dsRNA. EMBO J. 2017;36:761–782. doi: 10.15252/embj.201695000.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695000</ArticleId><ArticleId IdType="pmc">PMC5350567</ArticleId><ArticleId IdType="pubmed">28100675</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego J., Mendes A., Bourbon C., Camosseto V., Combes A., Liu H., Manh T.-P.V., Dalet A., Chasson L., Spinelli L., et al. Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2α dephosphorylation by the GADD34/PP1c complex. Sci. Signal. 2018;11:eaam8104. doi: 10.1126/scisignal.aam8104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aam8104</ArticleId><ArticleId IdType="pubmed">29363586</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavarino G., Cláudio N., Dalet A., Terawaki S., Couderc T., Chasson L., Ceppi M., Schmidt E.K., Wenger T., Lecuit M., et al. Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic: Polycytidylic acid-stimulated dendritic cells. Proc. Natl. Acad. Sci. USA. 2012;109:3006–3011. doi: 10.1073/pnas.1104491109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1104491109</ArticleId><ArticleId IdType="pmc">PMC3286954</ArticleId><ArticleId IdType="pubmed">22315398</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai R., Ohshima T. HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm. Oncogene. 2013;33:2317–2328. doi: 10.1038/onc.2013.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2013.181</ArticleId><ArticleId IdType="pubmed">23708656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesman A.W., Zijlstra-Willems E.M., Kaptein T.M., de Swart R.L., Davis M.E., Ludlow M., Duprex W.P., Gack M.U., Gringhuis S.I., Geijtenbeek T.B.H. Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases. Cell Host Microbe. 2014;16:31–42. doi: 10.1016/j.chom.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4159752</ArticleId><ArticleId IdType="pubmed">25011106</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasenosky L.D., Cadena C., Mire C.E., Borisevich V., Haridas V., Ranjbar S., Nambu A., Bavari S., Soloveva V., Sadukhan S., et al. The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus. iScience. 2019;19:1279–1290. doi: 10.1016/j.isci.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.07.003</ArticleId><ArticleId IdType="pmc">PMC6831822</ArticleId><ArticleId IdType="pubmed">31402258</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Li W., Zhang S., Qiu M., Li Z., Lin Y., Tan J., Qiao W., Kolawole A.O. Enterovirus 71 Activates GADD34 via Precursor 3CD to Promote IRES-Mediated Viral Translation. Microbiol. Spectr. 2022;10:e0138821. doi: 10.1128/spectrum.01388-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01388-21</ArticleId><ArticleId IdType="pmc">PMC8729766</ArticleId><ArticleId IdType="pubmed">34985336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brush M.H., Weiser D.C., Shenolikar S. Growth Arrest and DNA Damage-Inducible Protein GADD34 Targets Protein Phosphatase 1α to the Endoplasmic Reticulum and Promotes Dephosphorylation of the α Subunit of Eukaryotic Translation Initiation Factor 2. Mol. Cell. Biol. 2023;23:1292–1303. doi: 10.1128/MCB.23.4.1292-1303.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.4.1292-1303.2003</ArticleId><ArticleId IdType="pmc">PMC141149</ArticleId><ArticleId IdType="pubmed">12556489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Brush M.H., Choy M.S., Shenolikar S. Association with Endoplasmic Reticulum Promotes Proteasomal Degradation of GADD34 Protein. J. Biol. Chem. 2011;286:21687–21696. doi: 10.1074/jbc.M110.212787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.212787</ArticleId><ArticleId IdType="pmc">PMC3122225</ArticleId><ArticleId IdType="pubmed">21518769</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z., Wu W., Chen M., Cheng W., Yu J., Fang J., Xu L., Yasunaga J.-I., Matsuoka M., Zhao T., et al. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2. J. Virol. 2018;92:e00909-18. doi: 10.1128/JVI.00909-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00909-18</ArticleId><ArticleId IdType="pmc">PMC6258931</ArticleId><ArticleId IdType="pubmed">30258009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Yasunaga J.-I., Satou Y., Nakao M., Takahashi M., Fujii M., Matsuoka M. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB. Blood. 2009;113:2755–2764. doi: 10.1182/blood-2008-06-161729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-06-161729</ArticleId><ArticleId IdType="pubmed">19064727</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguero T., Jin Z., Chorghade S., Kalsotra A., King M.L., Yang J. Maternal Dead-end 1 promotes translation of nanos1 by binding the eIF3 complex. Development. 2017;144:3755–3765. doi: 10.1242/dev.152611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.152611</ArticleId><ArticleId IdType="pmc">PMC5675448</ArticleId><ArticleId IdType="pubmed">28870987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd R.E. Regulation of stress granules and P-bodies during RNA virus infection. WIREs RNA. 2013;4:317–331. doi: 10.1002/wrna.1162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1162</ArticleId><ArticleId IdType="pmc">PMC3652661</ArticleId><ArticleId IdType="pubmed">23554219</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiermann N., Haneke K., Sun Z., Stoecklin G., Ruggieri A. Dance with the Devil: Stress Granules and Signaling in Antiviral Responses. Viruses. 2020;12:984. doi: 10.3390/v12090984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090984</ArticleId><ArticleId IdType="pmc">PMC7552005</ArticleId><ArticleId IdType="pubmed">32899736</ArticleId></ArticleIdList></Reference><Reference><Citation>Heise M.T., Panas M.D., Schulte T., Thaa B., Sandalova T., Kedersha N., Achour A., McInerney G.M. Viral and Cellular Proteins Containing FGDF Motifs Bind G3BP to Block Stress Granule Formation. PLoS Pathog. 2015;11:e1004659. doi: 10.1371/journal.ppat.1004659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004659</ArticleId><ArticleId IdType="pmc">PMC4450067</ArticleId><ArticleId IdType="pubmed">25658430</ArticleId></ArticleIdList></Reference><Reference><Citation>White J.P., Cardenas A.M., Marissen W.E., Lloyd R.E. Inhibition of Cytoplasmic mRNA Stress Granule Formation by a Viral Proteinase. Cell Host Microbe. 2007;2:295–305. doi: 10.1016/j.chom.2007.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.08.006</ArticleId><ArticleId IdType="pubmed">18005751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Shetty M., Harding H.P., George G., Zyryanova A., Labbé K., Mafi A., Hao Q., Sidrauski C., Ron D. Substrate recruitment via eIF2γ enhances catalytic efficiency of a holophosphatase that terminates the integrated stress response. Proc. Natl. Acad. Sci. USA. 2024;121:e2320013121. doi: 10.1073/pnas.2320013121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2320013121</ArticleId><ArticleId IdType="pmc">PMC10998612</ArticleId><ArticleId IdType="pubmed">38547060</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.Y., Tkachuck D.C., Roberson R.S., Schubach W.H. The Human SNF5/INI1 Protein Facilitates the Function of the Growth Arrest and DNA Damage-Inducible Protein (GADD34) and Modulates GADD34-Bound Protein Phosphatase-1 Activity. J. Biol. Chem. 2002;277:27706–27715. doi: 10.1074/jbc.M200955200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200955200</ArticleId><ArticleId IdType="pubmed">12016208</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami K., Tambe Y., Watanabe R., Isono T., Haneda M., Isobe K.-I., Kobayashi T., Hino O., Okabe H., Chano T., et al. Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway. J. Virol. 2007;81:11106–11115. doi: 10.1128/JVI.01063-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01063-07</ArticleId><ArticleId IdType="pmc">PMC2045534</ArticleId><ArticleId IdType="pubmed">17670836</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R., Tambe Y., Inoue H., Isono T., Haneda M., Isobe K.-I., Kobayashi T., Hino O., Okabe H., Chano T. GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress. Int. J. Mol. Med. 2007;19:475–483. doi: 10.3892/ijmm.19.3.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.19.3.475</ArticleId><ArticleId IdType="pubmed">17273797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Jeyaraman K., Yusoff P., Shenolikar S. Phosphorylation At Tyrosine 262 Promotes GADD34 Protein Turnover. J. Biol. Chem. 2013;288:33146–33155. doi: 10.1074/jbc.M113.504407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.504407</ArticleId><ArticleId IdType="pmc">PMC3829162</ArticleId><ArticleId IdType="pubmed">24092754</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein P., Kallenberger S.M., Roth H., Roth K., Ly-Hartig T.B.N., Magg V., Ales J., Talemi S.R., Qiang Y., Wolf S., et al. Temporal control of the integrated stress response by a stochastic molecular switch. Sci. Adv. 2022;8:eabk2022. doi: 10.1126/sciadv.abk2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abk2022</ArticleId><ArticleId IdType="pmc">PMC8942376</ArticleId><ArticleId IdType="pubmed">35319985</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimoto K.-I., Takahashi H., Hishiki T., Konishi H., Fujita T., Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA. 2007;104:7500–7505. doi: 10.1073/pnas.0611551104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0611551104</ArticleId><ArticleId IdType="pmc">PMC1863485</ArticleId><ArticleId IdType="pubmed">17460044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack M.U., Shin Y.C., Joo C.-H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007;446:916–920. doi: 10.1038/nature05732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05732</ArticleId><ArticleId IdType="pubmed">17392790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack M.U., Nistal-Villán E., Inn K.-S., García-Sastre A., Jung J.U. Phosphorylation-Mediated Negative Regulation of RIG-I Antiviral Activity. J. Virol. 2010;84:3220–3229. doi: 10.1128/JVI.02241-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02241-09</ArticleId><ArticleId IdType="pmc">PMC2838087</ArticleId><ArticleId IdType="pubmed">20071582</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj N.P., Wies E., Stoll A., Gack M.U. Conventional Protein Kinase C-α (PKC-α) and PKC-β Negatively Regulate RIG-I Antiviral Signal Transduction. J. Virol. 2012;86:1358–1371. doi: 10.1128/JVI.06543-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06543-11</ArticleId><ArticleId IdType="pmc">PMC3264329</ArticleId><ArticleId IdType="pubmed">22114345</ArticleId></ArticleIdList></Reference><Reference><Citation>Wies E., Wang M.K., Maharaj N.P., Chen K., Zhou S., Finberg R.W., Gack M.U. Dephosphorylation of the RNA Sensors RIG-I and MDA5 by the Phosphatase PP1 Is Essential for Innate Immune Signaling. Immunity. 2013;38:437–449. doi: 10.1016/j.immuni.2012.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.11.018</ArticleId><ArticleId IdType="pmc">PMC3616631</ArticleId><ArticleId IdType="pubmed">23499489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657–662. doi: 10.1038/s41586-020-2601-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2601-5</ArticleId><ArticleId IdType="pmc">PMC7116779</ArticleId><ArticleId IdType="pubmed">32726803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>